A risk-benefit analysis of pioglitazone

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1483卷 / 1期
关键词：
D O I：
10.1007/s40278-014-7827-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [1] Cardiovascular Risk-Benefit Profile of Pioglitazone
    Hanefeld, M.
    Forst, T.
    Pfuetzner, A.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (01): : 37 - 43
  • [2] Risk-benefit analysis
    Mossman, KL
    [J]. HEALTH PHYSICS, 2002, 82 (05): : 750 - 750
  • [3] RISK-BENEFIT ANALYSIS
    ZENCEY, M
    [J]. ATLANTIC, 1979, 243 (04): : 37 - 37
  • [4] NEW INSIGHTS ON THE PIOGLITAZONE RISK-BENEFIT RATIO IN EUROPEAN POPULATION
    Arriagada, S.
    Gueyffier, F.
    Milles, R.
    Marchant, I.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E16 - E16
  • [5] Risk-benefit ratio or risk-benefit nonsense?
    Ernst, E
    Resch, KL
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (10) : 1203 - 1204
  • [6] THE FALLACIES OF RISK-BENEFIT ANALYSIS
    SAMUELS, SW
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1979, 329 (OCT) : 267 - 273
  • [7] Risk-benefit analysis of micronutrients
    Renwick, AG
    Flynn, A
    Fletcher, RJ
    Müller, DJG
    Tuijtelaars, S
    Verhagen, H
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2004, 42 (12) : 1903 - 1922
  • [8] PENTAMIDINE - A RISK-BENEFIT ANALYSIS
    WISPELWEY, B
    PEARSON, R
    [J]. DRUG SAFETY, 1990, 5 (03) : 212 - 219
  • [9] BIAS IN RISK-BENEFIT ANALYSIS
    MAZUR, A
    [J]. TECHNOLOGY IN SOCIETY, 1985, 7 (01) : 25 - 30
  • [10] A risk-benefit analysis of vaccination
    Heininger, Ulrich
    [J]. VACCINE, 2009, 27 : G9 - G12
12345